Brief: Vistagen Appoints Elissa Cote As Chief Corporate Development Officer
25/06/2025 13:37
June 25 (Reuters) - VistaGen Therapeutics Inc VTGN.O: VISTAGEN APPOINTS ELISSA COTE AS CHIEF CORPORATE DEVELOPMENT OFFICER Source text: ID:nBw8VbKMTa Further company coverage: VTGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors